Is serine racemase (SRR) a second hit target for LRRK2-G2019S induced Parkinson’s disease?
Sarah Louise Nickels, Jens Christian Schwamborn*
Luxembourg Centre for Systems Biomedicine (LCSB), University of Luxembourg, Belvaux, Luxembourg (Nickels SL, Schwamborn JC)
Riken Institute for Medical Sciences (IMS), Kanagawa, Japan (Nickels SL)
Online:2021-03-15
Published:2020-12-17
Contact:
Jens Christian Schwamborn, PhD, jens.schwamborn@uni.lu.
Sarah Louise Nickels, Jens Christian Schwamborn. Is serine racemase (SRR) a second hit target for LRRK2-G2019S induced Parkinson’s disease?[J]. Neural Regeneration Research, 2021, 16(3): 498-499.